attention us:
Product Catalogue
Contact information
Welcome to call the service hotline



Nervous system

Location>Home>Nervous system>N016:Leukoencephalopathy


     Leukoencephalopathy is a structural change in the brain, and the main characteristic is central nervous system cells to myelin damage,which play an advanced brain lesions involving the special features of white matter tracts. The clinical manifestations show inattention, forgetfulness and personality changes, to dementia, coma and even death. Genetic testing of leukoencephalopathy  is to use the target area capture technology and high-throughput sequencing technology, to detect and analysis the related genes of client's leukoencephalopathy. And in the meantime, it can be in early screening of patients with leukoencephalopathy, as well as to realize individualized medication and specificity of gene therapy to provide important basis for patients through combining with the history, clinical manifestation and information. Mygenostics is aimed to detect and analysis multiple subtypes of leukoencephalopathy by hand in hand with clinical experts, combined with a new generation of high-throughput sequencing technology and bioinformatics analysis, to provide reliable basis for early diagnosis of leukoencephalopathy patients.

Cerebral white matter - the panel covers 20 class epilepsy related diseases, the scope contains all the genes encoding exons zone and shear zone
1 Leukodystrophy, insufficient myelination
2 Metachromatic leukodystrophy
3 White matter melting encephalopathy
4 Adrenal cerebral white matter malnutrition
5 The deficiency of mitochondrial complex I
6 Spastic paraplegia is 35
7 Canavan
8 Leigh syndrome
9 Late onset of glutaric acid urine disease type II
10 Zellweger syndrome
11 Alexander disease
12 Spastic paraplegia 44 type
13 Other